Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Qbts - What They Never Told You

D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?

With D-Wave Quantum down over 32% YTD ahead of Q2 earnings, investors weigh quantum ETFs like WQTM and CQTM against individual stocks amid high valuations and slow sales growth.

MarketBeat

The Quantum Bubble Is Real Enough to Take Seriously

Quantum computing stocks like QBTS, RGTI, and IONQ trade at extreme valuation multiples despite low revenues, negative margins, and growing competition from IBM and Intel.

MarketBeat

How Does D-Wave's New Simulator Change the Quantum Computing Landscape?

D-Wave's new quantum simulator is a promising technological development that could entice new customers, but in some ways the firm is playing catch-up.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

D-Wave Just Unveiled a Major Quantum Breakthrough. QBTS Stock Looks Ready for Another Surge.

Despite weak Q1 revenue, surging bookings, and a growing backlog, suggest demand for D-Wave’s quantum offerings is accelerating.

Barchart

Trump Just Bet $2 Billion on Quantum Computing: Ranking IBM, QBTS and RGTI Stock Now

Trump’s $2 billion quantum computing investment reshaped the sector overnight. IBM looks safest, but pure-play investors face a tougher choice between D-Wave’s traction and Rigetti’s upside.

Barchart

D-Wave Quantum Q1 Earnings Call Highlights

D-Wave Quantum (NYSE:QBTS) reported a sharp increase in first-quarter bookings and said demand for its quantum computing systems has strengthened, even as revenue declined from a year earlier when results included a major system sale. On the company’s first-quarter 2026 earnings call, Chief Executi

MarketBeat

What's Behind D-Wave's Spring Rally, and Will It Continue?

D-Wave's recent rally appears to be a long-awaited turnaround after several months of declines, but promising news from NVIDIA may not yet translate to results.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Up Nearly 60% in 5 Days, Should You Chase the Rally in D-Wave Quantum Stock?

D-Wave stock charges higher on Nvidia’s launch of Ising AI models. Here’s why the announcement warrants buying QBTS shares in 2026.

Barchart

Is D-Wave the Latest Threat to Bitcoin?

A new threat to Bitcoin and the cryptocurrency industry more broadly may be emerging from quantum leaders like D-Wave Quantum.

MarketBeat

D-Wave Quantum Has Been Cut in Half—Can a Leveraged ETF Help Bulls?

D-Wave Quantum is already a highly speculative play in the quantum computing industry, but QBTX amplifies that risk—as well as the potential for rewards.

MarketBeat

MarketBeat Week in Review – 03/23 - 03/27

Stocks were down sharply this week as geopolitical risk elevates concerns about higher inflation and interest rates despite a temporary pause in hostilities

MarketBeat

Where's the Bottom, and When Will It Be Time to Sell D-Wave?

D-Wave Quantum is both overvalued and, likely, oversold. Here are some considerations investors might keep in mind before adding (or exiting) a position.

MarketBeat

D-Wave Keeps Delivering Good News—So Why Is It Falling?

D-Wave Quantum's lackluster share price performance this year doesn't seem to match its strong growth and promising tech, but what must happen to change that?

MarketBeat

MarketBeat Week in Review – 02/23 - 02/27

Technology stocks continue to be under pressure, and is flowing into defensive assets; investors should expect more volatility, which can create opportunities

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Despite a Double Miss, D-Wave's Earnings Could Fuel a New Rally

D-Wave confirmed that its growth trajectory remains impressive on multiple fronts, but it did come up short on top- and bottom-line figures for Q4 2025.

MarketBeat

Is This Quantum Outperformer a New Threat to D-Wave?

Quantum Computing may seem like a standout because it has fallen less than its quantum rivals, but QUBT comes with some significant warning signs.

MarketBeat

What to Make of D-Wave's Latest Defense Industry Push

D-Wave is once again making efforts to expand into the defense space with a promising partnership with Davidson and Anduril, but can it yield new sales?

Barchart

2 Top-Rated Quantum Computing Stocks to Buy on the Dip

Quantum computing stocks sold off on Thursday as Microsoft earnings dragged shares down.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

D-Wave’s Big Deal, Bigger Question: Can Sales Catch Up to the Hype?

D-Wave's big acquisition in January may have some investors worried about the company's ability to manage costs. Could a boost in sales be on the way to help?

MarketBeat

MarketBeat Week in Review – 01/26 - 01/30

Despite another volatile week, the overall outlook for stocks continues to look favorable with each of the major averages up more than 1% in January

MarketBeat

D-Wave Files $330 Million Shelf: Growth Fuel or Dilution Risk?

D-Wave's acquisition of Quantum Circuits could solidify its technological dominance in the quantum computing space, but funding continued growth is tricky.

MarketBeat

3 Key Ways D-Wave Is Developing an Advantage in Quantum Computing

D-Wave's recent acquisition announcement and a major technological breakthrough with implications for scalability help to set it apart amid setbacks for rivals.

MarketBeat

Inside D-Wave’s Major Acquisition—What Changes for Investors

D-Wave's planned $550-million purchase of Quantum Circuits will give it a big leg up technologically. But the company still faces commercialization questions.

Barchart

D-Wave Just Got a ‘Formidable’ Quantum Computing ‘Ally.’ Should You Buy QBTS Stock Here?

Is QBTS seen as a high-risk, high-reward bet as an early quantum leader or a core holding for conservative portfolios?

MarketBeat

D-Wave’s Year in Review: 2025 Wins Set the Stage for 2026

D-Wave had a successful year in 2025, marked by growing revenue, major sales, new technological advances, and more. This bodes well for 2026, but risks remain.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.